Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FLIBANSERIN
- Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
- Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)
- Hypoactive Sexual Desire Disorder in Males
- Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
- Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
- Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)
- to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers
- A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
- Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
- 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
- Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
- Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
- Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder
- Flibanserin Versus Placebo in Premenopausal Women With HSDD
- A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
- Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
- 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
- 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
- Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
Clinical trials list
click for details